Alto Neuroscience earnings were -$61.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ANRO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$15.2M, down 9.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ANRO reported annual earnings of -$61.4M, with 69.2% growth.
What were Alto Neuroscience's earnings last quarter?
Alto Neuroscience (NYSE: ANRO) reported Q4 2024 earnings per share (EPS) of -$0.56, up 81.21% year over year. Total ANRO earnings for the quarter were -$15.20 million. In the same quarter last year, Alto Neuroscience's earnings per share (EPS) was -$2.98.
As of the last Alto Neuroscience earnings report, Alto Neuroscience is currently losing money. Alto Neuroscience's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$61.43 million, a 69.21% increase year over year.
What was ANRO's earnings growth in the past year?
As of Alto Neuroscience's earnings date in Q2 2025, Alto Neuroscience's earnings has grown year over year. ANRO earnings in the past year totalled -$61.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.